Nemaura Medical Inc. is a medical technology company which has developed sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) designed to improve glucose management for all people with diabetes and pre-diabetics. SugarBEAT® consists of a daily-disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings at five-minute intervals for periods of up to 24 hours. Nemaura was founded in 2009 and is headquartered in Loughborough, United Kingdom.
The medtech company is looking at explosive growth with sugarBEAT launching in the UK, followed by the rest of Europe
